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Abstract 
Traditionally, the mammalian neuromuscular junction, the primary synapse found in 
skeletal muscle, has been termed the “simple synapse” for its basic chemical signaling 
mechanisms as compared to central nervous system synapses. However, recent data has 
suggested that the neuromuscular junction is far more complex than initially perceived and that 
various proteins are involved in the orchestration of synaptic function and development. One 
such protein, Ca
2+
/calmodulin associated serine/threonine kinase (CASK), has been previously 
identified as a key component in neuronal development. Our lab has found that CASK is 
concentrated at the neuromuscular junction, cytoplasm, and nuclei of skeletal muscle fibers, 
where evidence suggests that it may play a role in the structural scaffolding of synapses, receptor 
trafficking, protein phosphorylation, and transcription. To further elucidate the mechanisms of 
CASK in skeletal muscle, we have generated two distinct conditional knockout murine models of 
CASK in skeletal muscle. One model represents a knockout of non-synaptic CASK, while the 
other model represents a knockout of CASK in both the cytoplasm and at the neuromuscular 
junction. Recent data has shown that mice without CASK at the neuromuscular are not born at 
the predicted Mendelian ratios, while mice only deficient of cytoplasmic CASK show no 
observable phenotype. Further analyses of these models will be necessary to help to define the 
function of CASK in skeletal muscle. Studying the neuromuscular junction is the key to 
understanding the underlying mechanisms of neuromuscular diseases.  Delineating the functions 
of CASK in skeletal muscle may lead to the identification of novel treatment approaches for 
neuromuscular diseases. 
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I  
Introduction 
Significance 
 Neuromuscular disorders encompass a large number of diseases with a wide array of 
etiology and severity, many of which are fatal in childhood. With the exception of few, most of 
these diseases are incurable, and will result in eventual death due to gradual muscle weakness, 
breathing problems, and/or heart failure. Neuromuscular diseases are caused by abnormalities in 
skeletal muscle, motor neurons, or the neuromuscular junction; yet many of the underlying 
molecular mechanisms of these diseases have yet to be determined (Bushby et. al. 2009, Lee et. 
al. 2009,  McConville and Vincent 2002, Sandona et. al. 2009, Stavarachi et. al. 2010, Turner et. 
al. 2010). Currently, there are few effective treatments for neuromuscular diseases (Aartsma-Rus 
and van Ommen 2010, Muir and Chamberlain 2009, Tang et. al. 2010, Trollet et. al. 2009, Wood 
et. al. 2010). 
The key to understanding and learning more about the mechanisms behind such diseases 
lies at the interface between the nervous system and skeletal muscle: the mammalian 
neuromuscular junction. Since nearly every neuromuscular disorder has an underlying genetic 
basis, an in depth understanding of protein function at the neuromuscular junction is of utmost 
importance when defining the molecular mechanisms of disease (Cardamone et. al. 2008). Many 
proteins have been characterized at the neuronal synapse, helping to elucidate the mechanisms 
behind several neurological diseases. Additional knowledge of the functions of newly identified 
classes of proteins at the neuromuscular junction that are involved in skeletal muscle and 
neuromuscular junction development may lead to the identification of novel treatment 
approaches for neuromuscular diseases.  
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Muscle Development 
 The embryonic development of skeletal muscle requires a coordinated regulation of 
various cell types and myogenic factors. In the developing embryo, cell clusters called somites 
arise from the mesoderm to eventually differentiate into three cell types: skin, vertebrae, and 
skeletal muscle. Cells located in the dorsal part of the somites begin to form the dermomyotome, 
which is responsible for forming the musculature. The dermomyotome will divide to form 
myoblasts, or muscle progenitor cells, which through the action and up- or down-regulation of 
several myogenic regulatory factors, notably Myf5 and MyoD, will fuse together to form 
myofibers, the cellular units of mature skeletal muscle (Figure 1-1) (Bakkar and Guttridge 2010, 
Buas and Kadesch 2010, Gros et. al. 2005, Hollway and Currie 2005, Krauss et. al. 2005, Otto 
and Patel 2010, Te and Reggiani 2002).  
 Adult skeletal muscle is made up of many bundles of myofibers. Myofibers are 
multinucleated, cylindrical structures with nuclei that characteristically localize to the periphery 
of the cell membrane. Myofibers can further be broken down into repeating units called 
sarcomeres, which are organized arrangements of the proteins actin and myosin (Bloch et. al. 
2002, Kee et. al. 2002, Luther 2009, Pinotsis et. al. 2009, Sanger and Sanger 2008, Sparrow and 
Schock 2009). These proteins are responsible for the contractile properties of skeletal muscle, 
and function in response to membrane depolarization and a corresponding increase in 
intracellular calcium levels (Endo 2009, Hezog 2008, Rosenberg 2009).  
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Synaptic Scaffolding and the Neuromuscular Junction 
 The mammalian neuromuscular junction (NMJ) refers to the site where a skeletal muscle 
fiber is innervated by a single motor neuron. When the brain initiates the response to move, a 
nerve impulse is conducted through the central and peripheral nervous systems to the NMJ. At 
this location, the presynaptic motor neuronal axon releases acetylcholine (ACh), a major 
excitatory neurotransmitter in the body responsible for membrane depolarization. ACh travels 
across the synapse where it binds to homogenous receptors embedded within the invaginated 
postsynaptic membrane of a skeletal muscle fiber. ACh receptors are located at the tops of the 
folds of the invaginated skeletal muscle, referred to as the primary gutter. Binding of ACh to 
these receptors produces a rise in intracellular calcium levels and subsequent muscle contraction 
(Burden 1998, Hughes 2006, Glass et. al. 1996, Glass et. al. 1997, Madhavan and Peng 2003, 
Madhavan 2005, Meyer and Wallace 1998, Patton 2003, Ruegg and Bixby 1998, Sanes and 
Lichtman 1999, Wu 2010).  
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ACh receptor complexes play a crucial role in synaptic scaffolding and function of the 
vertebrate NMJ. However, there are various other proteins that are involved in the scaffolding, 
stabilization, development, function, and orchestration of this chemical synapse. One such family 
of proteins found in cell-cell junctions, such as the NMJ, are the membrane-associated guanylate 
kinases (MAGUKs), which share the defining characteristic of containing multiple protein-
protein interaction domains. MAGUKs are believed to interact with each other, as well as 
channels and receptors, via their PDZ domains, which were coined after the proteins in which 
they were first discovered (PSD-65, Discs Large, and Zo-1). In addition to PDZ, MAGUKs also 
contain a number of other protein-interactor domains, including a HOOK domain, an SH3 
domain (Src homology 3), a guanylate kinase domain (GK), and two L27 domains (initially 
discovered in the proteins lin-2 and lin-7) (Anderson 1996, Craven et. al. 1998, Garner et. al. 
2000, Kim et. al. 2004, Kornau et. al. 1997, Pawson et. al. 1997). One notable MAGUK protein, 
Ca
2+
/calmodulin-associated serine/threonine kinase (CASK), has been proven to facilitate the 
development of cell junctions throughout the body and is essential to sustain life (Laverty and 
Wilson 1998). Recently, CASK has been shown to be present throughout skeletal muscle fibers 
and concentrated at the NMJ, where we hypothesize that it plays a major role in synaptic 
development and/or function (Sanford et. al. 2004, Sanford et. al. 2008). 
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An Overview of CASK 
CASK is composed of every characteristic MAGUK domain, and is unique in that it also 
contains an N-terminal CaMK (Ca
2+
/calmodulin kinase-like) domain. The PDZ domain of CASK 
is one of the main indicators of its involvement in synaptic scaffolding (Daniels et. al. 1998). 
CASK has been shown to bind and interact with neurexin-1, a postsynaptic scaffolding protein 
that aids in the structural development of the synapse via its binding to the presynaptic protein 
neuroligin (Biederer et. al. 2001, Hata et. al. 1996, Zhang et. al. 2001). CASK also has the ability 
to cluster inward-rectifying potassium channels and form complexes with other structural 
proteins by means of its PDZ domain (Kim et. al. 1995, Leonoudakis et. al. 2001, 2004). Its other 
characteristic MAGUK domains are also believed to be involved in the interaction and 
trafficking of other various proteins (Biederer et. al. 2001, Borg et. al. 1998, Daniels et. al.  1998, 
Dimitratos et. al. 1997, Ferguson et. al. 1985, Hata et. al. 1996, Hoskins et. al. 1996, Maximov 
et. al.1999, Leonoudakis et. al. 2004, Zhang et. al. 2001). The HOOK domain, notably, is 
thought to confer an intermolecular binding between the SH3 and GK domain of CASK, a 
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potential means by which the CASK protein may biochemically regulate its own trafficking, 
localization, and protein interactions (Hoover et. al. 2000, Kohu et. al. 2002, McGee et. al. 1999, 
2001, Tavares et. al. 2001). 
CASK is an X-linked protein that was first discovered in mammals based on its 
interaction with neurexin, thought to function in stabilizing the neuronal synapse (Biederer et. al. 
2001, Hata et. al. 1996, Sun et. al. 2009, Zhang et. al. 2001). It has also been previously 
identified as a key protein in the development of C. elegans.  Lin-2, the CASK homolog in C. 
elegans, demonstrates the first in vivo evidence of the capability of CASK to cluster potassium 
and calcium channels by means of its PDZ domain. It was in this model that CASK was shown 
to form a tripartite complex with two other PDZ domain-containing proteins, Mint and Veli 
(Borg et. al. 1998, Butz et. al. 1998, Kaech et. al. 1998, Simske et. al. 1996)  This complex has 
been proposed to serve as a mechanism for the recruitment of calcium channels and other 
receptors, as well as a means to facilitate vesicle exocytosis (Butz et. al. 1998, Maximov et. al. 
1999, Schuh et. al. 2003) .  
The GK and CaMK domains of CASK share a similar structural and sequence homology 
with traditional kinases, however, until recently CASK was not thought to be involved in 
phosphorylation. The presence of the CaMK domain had led to the hypothesis that CASK may 
be involved in the phosphorylation of the neuron-specific adhesion molecule, neurexin, as well 
as certain other protein interactors, such as Discs large (Dlg). CASK’s inability to bind Mg2+, a 
traditional catalyst for phosphorylation, had previously led to the speculation that CASK may be 
a pseudokinase with phosphorylative abilities yet to be determined. However, recent evidence 
suggests a potential kinase activity of CASK despite its lack of Mg
2+
 -binding sites (Mukherjee 
et. al. 2008, 2010). 
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CASK’s unique combination of domains allow for it to have a complex and adaptive role 
within the changing environment of the developing skeletal muscle. The essential role of CASK 
in development has been demonstrated through models in which a complete knockout of CASK 
protein in mouse results in cleft palate and neonatal death (Laverty and Wilson 1998). More 
recently, disruptions in the CASK protein have also been linked to a variety of X-linked mental 
retardations, further illustrating its important function in development (Bailey and Aldinger 
2009, Hackett et. al. 2010, Hayashi et. al. 2008, Hsueh 2009, Najm et. al. 2008,  Piluso et. al. 
2009, Tarpey et. al. 2009). More pertinent to muscle development, our lab has shown that CASK 
localizes to the nucleus in developing myoblasts, while migrating to the cytoplasm in 
differentiated myotubes, suggesting a mechanism of protein trafficking during development 
(Gardner et. al. 2006). The potential ability of the CaMK domain to function as a kinase without 
functional Mg
2+
 binding sites may provide a means for the phosphorylation of other proteins 
when traditional kinases exhibit a depressed function in the Mg
2+
-poor environment of 
developing skeletal muscle.  
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CASK has already been shown to function as a scaffolding protein in central nervous 
synapses of the brain, and is capable of functioning as a kinase and transcription factor (Huang 
et. al. 2009, Hsueh et. al. 2000, Wang et. al. 2004a, 2004b). The presence of CASK in skeletal 
muscle and at the neuromuscular junction suggests that it may play a similar role at this location. 
Its combination of functional protein-interaction domains suggests it may play an adaptive role 
in muscle development, and interaction with various other proteins may allow for CASK to play 
an important role in formation and stabilitzation of the NMJ, as well as receptor trafficking and 
cell function. 
 
Objectives 
 The goal of this study is to focus on defining the functions of the MAGUK protein CASK 
in skeletal muscle and at the neuromuscular junction. The overarching hypothesis that CASK is 
involved in the structural scaffolding of synapses, receptor trafficking, and protein 
phosphorylation throughout developing skeletal muscle will be tested in two distinct conditional 
knockout models: one that exhibits a loss of cytoplasmic CASK and the other that exhibits a 
complete loss of CASK in skeletal muscle in the cytoplasm and at the neuromuscular junction. 
Specifically, the study seeks to characterize a phenotype associated with each model, determine 
CASK’s ability to alter the levels of various other protein interactors, and CASK’s ability to 
influence the phosphorylation of other known NMJ proteins. This comprehensive 
characterization of CASK’s function at the NMJ will help to elucidate the molecular mechanisms 
by which abnormalities in NMJ and skeletal muscle development can lead to neuromuscular 
disease. 
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II 
Characterization of Non-Synaptic CASK Function in Skeletal Muscle 
Introduction 
In adult murine skeletal muscle, CASK protein is found localized to the membrane, 
cytoplasm, select nuclei, and is most enriched to the post-synaptic side of the NMJ (Sanford et. 
al. 2004). However, many of its functions in skeletal muscle have yet to be defined. CASK, via 
its PDZ domain, has already been shown to play a role in receptor trafficking to the synapse in 
neuronal cultures (Hata et. al. 1996, Leonoudakis et. al. 2001, 2004). CASK adopts a 
conformation that can bind calcium channels and NMDA receptor subunits, a subtype of 
glutamate receptors, and localizes them in clusters to neuronal synapses in culture (Maximov et. 
al. 1999, Nagano et. al. 1998). CASK is also thought to stabilize the neuronal synapse via its 
interaction with neurexin-1 (Hata et. al. 1996). The presence of CASK in the cytoplasm of 
skeletal muscle and at the post-synaptic membrane leads us to formulate the hypothesis that 
CASK may also be involved in channel clustering and protein trafficking to the mammalian NMJ 
(Sanford et. al. 2004, Sanford et. al. 2008). 
Additionally, it has been shown that CASK interacts in vivo in skeletal muscle with 
another MAGUK protein, Discs large (Dlg) (Sanford et. al. 2004). Dlg has also been shown to 
bind glutamate receptors and potassium channels, and its formation of a complex with CASK at 
the NMJ further supports the role that CASK may play in protein trafficking in skeletal muscle 
(Nagano et. al. 1998, Tejedor et. al. 1997). Dlg also contains a PDZ domain, and has also been 
implicated in the trafficking of receptors to synapses (Lue et. al. 1996). Evidence suggests that 
CASK and Dlg may share a similar role in vivo, and knockouts of either CASK or Dlg protein 
function in mice show similar neonatal lethal phenotypes (Lee et. al. 2002, Nix et. al. 2000). 
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CASK and Dlg also form a tripartite complex with the inward-rectifying potassium channel 
subunit Kir2.2, also suggesting their ability to cluster channels (Leonoudakis et. al. 2001, 2004). 
We hypothesize that CASK interacts with other MAGUK proteins, protein channels, and 
receptors in skeletal muscle, and we set out to delineate the functions of CASK in vivo. 
 One widely used method of protein characterization is the generation and study of a total 
knockout (KO) mouse model, in which the gene is disrupted and the encoded protein is absent in 
all tissues. A resulting phenotype then can be characterized to determine the function of the 
protein of interest in vivo. CASK was first knocked-out by Laverty et al due to a transgenic 
insertion in the CASK locus. These CASK KO mice exhibited cleft palate and died within 24 
hours of birth (Laverty et. al. 1998). However, muscle tissue was not studied in this initial CASK 
KO model, and the phenotype was not associated with CASK function in a specific tissue.  
Another widely used method to delineate protein function in vivo is through the 
generation of conditional knockout (cKO) murine models. In this instance, the gene can be 
disrupted only in a specific tissue, so that the resulting phenotype can be attributed to the loss of 
function of the target protein in a specific tissue. To determine the role that CASK plays in 
skeletal muscle, our lab generated cKO models of CASK in which the protein was ablated 
specifically in skeletal muscle tissue. This was done so that we could attribute any resultant 
phenotype to skeletal muscle pathology. To develop these models, we used a method known as 
the Cre/lox recombination system (Sternberg et. al. 1981). This system requires the insertion of 
two palindromic genetic sequences known as “locus of crossover P1” (loxP) sites on the same 
chromosome and the presence of an enzyme known as Cre recombinase (Cre). When the loxP 
sites are inserted around a portion of a gene, (at which point the gene is termed “floxed”), Cre 
will cause a recombination event between the two loxP sites, excising the intervening DNA and 
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leaving one loxP site remaining, effectively interrupting the gene (Hoess et. al. 1985). The floxed 
gene will be present in every cell in an organism; however, the Cre transgene can be linked to a 
specific promoter activated only in certain tissues to ensure tissue-specific protein ablation. To 
achieve skeletal muscle specific CASK gene knockout, we obtained a mutant line of mice that 
exhibited a floxed portion of the CASK gene that was initially developed by Atasoy et al. We 
then mated these mice with mice expressing Cre recombinase from the Human Skeletal Actin 
(HSA) promoter, a promoter expressed in terminally differentiated skeletal muscle fibers 
(Miniou et. al. 1999). In the resulting experimental mice (CASK SkM cKO), Cre will only be 
expressed in skeletal muscle to generate a skeletal muscle specific ablation of CASK. Study of 
these mice will allow us to test hypotheses about CASK functions in skeletal muscle. 
Due to the multiple proposed physiological roles of CASK, including receptor 
trafficking, protein phosphorylation, transcription, and synaptic scaffolding, we postulate that a 
complete ablation of CASK protein in skeletal muscle will result in a degenerative and 
pathological phenotype (Hata et. al. 1996, Leonoudakis et. al. 2004, Mukherjee et. al. 2008, 
Sanford et. al. 2004). We hypothesize that CASK plays an essential role in skeletal muscle by 
binding to and trafficking receptors and protein channels to the NMJ.  
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Methods 
CASK Knockout Mice and the HSA Transgenic Line 
 Mice possessing a floxed allele with lox P sites surrounding exon 1 of the CASK gene on 
the X-chromosome were generated by Atasoy et al. and made available for purchase from 
Jackson Laboratories. These mice were used to breed the CASK SkM cKO mouse model. The 
HSA-Cre transgenic mice were generated by Miniou et al. and possess the Cre recombinase 
transgene linked to the muscle-specific promoter human skeletal actin (HSA).  In order to 
generate the CASK SkM cKO mice, we first bred female CASK flox mice to male mice carrying 
the HSA-Cre transgene (Cre
+
), producing an F1 generation that resulted in both wild-type (WT) 
and CASK flox mice (flox) with or without the HSA-Cre transgene. These genotypes are 
referred to as follows: Male mice possessing a floxed CASK allele and the HSA-Cre transgene 
are CASK cKO males (cKO), CASK flox males without the Cre transgene (flox/-), females 
heterozygous for the floxed allele with the Cre transgene (Het/+), or without (Het/-), and wild 
type mice with the Cre transgene (WT/+), or without (WT/-). Because CASK is an X-linked 
gene, the breeding scheme favors male knockouts. Experiments were conducted on CASK cKO 
males with WT/+, WT/-, and flox/- littermate controls. Subsequent matings were maintained by 
mating Het/- females to WT/+ males. 
 All mice are housed in a fully-equipped vivarium at The Ohio State University under an 
IACUC approved protocol to Dr. Jill Rafael-Fortney. Mice are kept on a standard 12 hr day/night 
cycle and were provided food (7012 Teklad LM-485 Mouse/Rat Sterilizable Diet, Harlan 
Laboratories) and water ad libitum. 
 
 
19 
 
Genotyping of Mice 
 Genomic DNA was obtained from tail biopsies of mice and analyzed via the polymerase 
chain reaction (PCR). To test for the presence of the HSA-Cre transgene, primers were designed 
to screen for a DNA sequence within the Cre region, as initially described by Miniou et al. This 
first pair of primers are as follows: HSA-Cre Forward (5’ CCGGTCGATGCAACGAGTGAT 
3’) and HSA-Cre Reverse (5’ ACCAGAGTCATCCTTAGCGCC 3’), resulting in a 790 bp 
product at a 56
o
C annealing temperature. Genotyping for presence of the floxed allele was 
performed using two sets of primers. The first primer set was designed to screen for a region 
within the neomycin resistance (Neo) cassette, and are as follows: CASK Neo Rejuv Forward (5’ 
GCTATGACTGGGCACAAC 3’) and CASK Neo Rejuv Reverse (5’ 
GCCAACGCTATGTCCTG 3’), yielding a 610 bp product at 56oC annealing temperature. 
A second primer set was used in conjunction with CASK cKO Rejuv F/R to confirm the 
presence of the floxed allele, and are as follows: IMR 6389 (5’ 
CGCATCGCCTTCTATCGCCTTCTT 3’) located within the Neo cassette and IMR 6390 (5’ 
CACCCACCCACTCATGCTTCTGC 3’) located within the CASK genomic sequence, yielding 
a 256 bp product at 58
o
C annealing temperature. To test for the presence of the wild type allele, 
primers were designed to screen for a DNA sequence around the Neo cassette of the targeting 
sequence generated by the Jackson Labs. Primers included in this set are as follows: SSC 221 (5’ 
AGGCCTTGCAAATCATCGTTCAT 3’) and IMR 6388 (5’ 
CTCTCCAAATCTCCTTACCTCAA 3’), yielding a 490 bp product for the WT allele and a 
1,400 bp product for the floxed allele at 60
o
C annealing temperature. All PCR reaction products 
were run on 1% agarose gels (0.02% ethidium bromide) and photographed under ultraviolet 
light. 
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Histological Analysis 
 Unfixed quadriceps muscles were dissected from WT, Flox, and CASK cKO mice at 12 
weeks of age and embedded in OCT (optimal cutting temperature) cryoprotective mounting 
medium (Tissue-Tek, Hatfield, PA). Tissues were then slow-frozen on liquid nitrogen-cooled 
isopentane and stored at -80
o
C.  Frozen tissue was cut into 8 µm cross-sections on a cryostat. To 
view the histology of the section, slides were fixed in 100% ethanol and stained with 
hematoxylin and eosin (H&E) using a standardized protocol.  
 
Immunohistochemistry 
 Immunohistochemical analysis was conducted on 8 µm cross-sections of unfixed frozen 
quadriceps from WT, Flox, and CASK cKO mice aged 12 weeks.  Sections were first blocked in 
1% gelatin in potassium-phosphate buffered saline (KPBS) for 15 min before being washed in 
KPBS for 15 min. Following the washes, sections were incubated for 2 hours in a primary 
antibody solution consisting of primary antibody diluted in KPBSG (KPBS + 0.5% gelatin) plus 
normal goat serum (1%). Primary antibodies used include: CASK polyclonal (Zymed, 1:25), Dlg 
polyclonal (a kind gift from A. Chishti, 1:1,250), and Grip polyclonal (Chemicon, 1:50). 
Sections were then washed 3 x 5 min in KPBSG. Following rinsing, sections were incubated in a 
secondary antibody solution that consists of CY3 anti-rabbit secondary antibody (Jackson 
Laboratories, 1:200), Alexa 488-conjugated α-bungarotoxin (Molecular Probes, Inc., 1:1000), 
normal goat serum (1%), in KPBSG for 1 hour. α-bungarotoxin was used to fluorescently label 
the NMJ. After incubation, sections were once again washed in KPBSG 3 x 5 min. Slides were 
then mounted in Vectashield ® (Vector Labs, Burlingame, CA) and 4',6-diamidino-2-
phenylindole (DAPI, 500 ng/mL ), a DNA-tagging fluorescent dye used for nuclei visualization, 
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before being coverslipped. Images were captured with a Nikon Eclipse E800 microscope and a 
SPOT-RT slider digital camera and SPOT® software.  
 To view the topology of the neuromuscular junction, quadriceps from 12 week old mice 
were dissected and preserved in 1% paraformaldehyde in KPBS for 1 hour, followed by 
immersion in 20% sucrose in KPBS overnight. Tissue was then embedded in mounting medium 
and frozen down on liquid nitrogen-cooled isopentane, as done previously. 30 µm transverse 
sections of quadriceps were cut and placed onto slides. For immunohistochemical analysis, slides 
were equilibrated in KPBS for 5 min and washed in 0.1 M glycine in KPBS for 1 hour. Sections 
were then extracted on ice in 0.5% Triton X-100 in KPBS for 5 min. Slides were then washed in 
KPBS and blocked in 1% gelatin in KPBS for 1 hour. To fluorescently label the NMJ, sections 
were incubated for 3 hours in an antibody solution consisting of Alexa-488 conjugated α-
bungarotoxin (1:200) and normal goat serum (1%) in KPBSG. Following incubation, sections 
were washed 3 x 15 min in KPBS with 0.1% Tween-20, mounted in Vectashield, and 
coverslipped. The circumference of each NMJ in every section was traced and quantitatively 
measured using SPOT® software. Sizes were averaged and compared across the different 
genotypes.  
 Confocal analysis was performed by Jamie Sanford on 8 µm cross-sectioned quadriceps 
from 12 week old mice that had been fixed in 1% paraformaldehyde and 20% sucrose and 
frozen, as described above.  Slides were then equilibrated in KPBS, washed in 0.1 M glycine, 
and extracted in 0.5% Triton X-100, as done when staining for NMJ topology.  Slides were 
blocked in 1% gelatin in KPBS for 1 hour and incubated in primary antibody solution, consisting 
of primary antibody diluted in KPBSG plus 1% normal goat serum. Primary antibodies include 
CASK polyclonal (Zymed, 1:25) and Dlg polyclonal (a kind gift from A. Chisti, 1:1,250). Slides 
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were washed 3 x 15 min in KPBS and incubated in a secondary antibody solution that consists of 
CY3 anti-rabbit secondary antibody (Jackson Laboratories, 1:200), Alexa 488-conjugated α-
bungarotoxin (Molecular Probes, Inc., 1:1000), and normal goat serum (1%) in KPBSG for 3 
hours. Slides were washed in 0.1% Tween-20 in KPBS 3 x 15 min and mounted in Vectashield 
and coverslipped.  
 
Subcellular Fractionation 
 Dissected skeletal muscle tissue was homogenized in 7.5 volumes of Homogenization 
buffer (20 mM sodium pyrophosphate, 20 mM sodium phosphate monobasic, 1 mM MgCl2, 303 
mM sucrose, 0.5 mM EDTA, pH 7.1) and then centrifuged for 15 min at 14,000 x g. The 
supernatant was then collected and filtered through cheesecloth to isolate the S1 fraction, which 
consists of cytoplasmic organelles. This fraction was then centrifuged for 37 min at 142,413 x g 
and the supernatant was discarded. The pellet was then resuspended in 70% original volume of 
Resuspension Buffer I (0.6 M KCl, 0.3 M sucrose, 50 mM Tris-Cl, pH 7.4, 0.1 mM PMSF 
protease inhibitor, 0.75 mM benzamidine) and centrifuged again for 37 min at 142,413 x g. 
Following the spin, the supernatant was collected and saved as the S2 fraction, also consisting of 
cytoplasmic organelles, and the pellet was resuspended in 0.3 volumes of Resuspension Buffer II 
(10 mM sodium phosphate, 5 mM EDTA, 150 mM NaCl, pH 7.8). The resuspended was saved 
as the isolated microsome fraction, consisting of membrane-bound proteins. Western analysis 
could then be performed on homogenates, S1, S2, and microsome fractions to determine the 
levels of protein in each different cell fraction. 
 Nuclear extract (NE) fractions were also isolated separately from total skeletal muscle 
homogenates. Homogenates were resuspended in CE buffer (10 mM HEPES, pH 7.6, 60 mM KCl, 
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1 mM EDTA, protease inhibitors) plus NP-40 nonionic detergent (0.25%) and incubated for 5 min 
on ice. Samples were then spun at 718 x g for 4 min at 4
o
C. The pellet is then isolated and 
washed in CE buffer without NP-40 and spun for another 4 min at 718 x g at 4
o
C. The pellet was 
then resuspended again in CE buffer without NP-40 and carefully layered on top of 2 mls of 
Buffer B (30% sucrose, 60 mM KCl, 15 mM NaCl, 15 mM HEPES, pH 7.5, 2 mM EDTA, 0.15 
mM spermine, 0.75 mM spermidine, 1 mM DTT). Samples were then spun at 1,643 x g for 15 
min at 4
o
C. The pellet was isolated and resuspended in CE buffer without NP-40 and carefully 
layered on top of 2 mls of Buffer C (same as Buffer B with 50% sucrose). Samples were again 
spun at 1,643 x g for 15 min at 4
o
C before the pellet was isolated and resuspended in 200-300 µL 
of NE buffer (20 mM Tris pH 8.0, 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, protease 
inhibitors). Samples were then incubated on ice for 10 min before spun down once more a 1,643 
x g for 10 min to pellet anything insoluble. The supernatant was then saved as the nuclear extract 
(NE) fraction and stored at -80
o
C. 
 
Western Analysis 
 Total skeletal muscle was collected from 12-week old WT, Flox, and CASK SkM cKO 
mice and homogenized in Newcastle buffer (75 mM Tris, pH 6.8, 3.8% sodium dodecyl sulfate 
(SDS), 4 M urea, 20% glycerol). Protein concentrations were determined using the DC protein 
assay (Biorad) followed by subsequent absorbance measurements at 750 nm wavelength. 50 µg 
of protein per sample was then run out on 8% SDS-polyacrylamide gel electrophoresis (SDS-
PAGE) gels at 80 V for approximately 3 hours. After separation, proteins were electrically 
transferred from SDS-PAGE gels to nitrocellulose (Whatman International) at 80 V for 90 min 
using a wet transfer apparatus (Bio-Rad). Nitrocellulose Western blots were then blocked in 3% 
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bovine serum albumin (BSA) in Tris-buffered saline plus 0.1% Tween-20 (TBST) and 1% 
normal goat serum for 1 hour. Blots were then incubated in a primary antibody solution 
consisting of a primary antibody and 1% normal goat serum in TBST for 2 hours. Primary 
antibodies include CASK polyclonal (Zymed, 1:250), Dlg monoclonal (Transduction 
Laboratories, 1:250), and Pan-Maguk monoclonal (UC Davis, 1:250). Blots were then washed 3 
x 15 min in TBST and incubated with horseradish peroxidase (HRP)-conjugated goat anti-rabbit 
secondary antibody (Jackson Laboratories, 1:10,000) in TBST with 1% normal goat serum for 1 
hour. Chemiluminescence (Amersham) was used for detection of bound primary antibody. 
 
Physiological Analysis 
 The following procedure was performed by the laboratory of Dr. Paul Janssen. Extensor 
digitorum longus (EDL) muscle was dissected, tendon to tendon, from 12-week old WT/+ and 
CASK SkM cKO mice. Muscles were attached horizontally by their tendons to a force 
transducer and an electromagnetic length adaptor in Krebs solution. Optimum length of the EDL 
was determined by subjecting the muscle to successive twitches and measuring the length at 
which maximum isometric force is achieved. Maximum tonic contraction was measured by 
subjecting the muscle to 5 tetanic stimulations of 350 ms at 2 minute intervals, using a 
stimulation frequency of 125 Hz. Measurements were expressed per unit cross-sectional area 
(mN/mm
2
). 
 
 
 
 
25 
 
Results 
Generation of HSA-Cre CASK SkM cKO Mice 
The CASK SkM cKO mice were generated via the Cre/lox recombination system. Mice 
that possess the floxed CASK allele were mated to mice that express the Cre transgene from the 
HSA promoter to interrupt the CASK gene specifically in skeletal muscle tissue. This generates a 
generation of mice that include: CASK SkM cKO males, flox/- males, het/+ females, het/- 
females, and WT/+ and WT/- mice (figure 2-2). Genotypes of mice were observed at the 
expected Mendelian ratios. CASK SkM cKO mice showed no obvious muscle weakness, labored 
breathing, or gross phenotypes. Mice of each genotype were viable for at least 12 months.  
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CASK Ablation Occurs in the Cytoplasm but Not at the NMJ 
 To determine the efficacy of the HSA-Cre CASK skeletal muscle cKO model, western 
analysis of total skeletal muscle homogenates from 12 week old WT Cre transgenic positive 
(WT/+) and CASK cKO mice was performed (figure 2-3). Relative protein levels revealed that 
CASK expression had been almost entirely ablated in the CASK cKO muscle as compared to a 
strong band in the WT/+ homogenates. Verification of a loss of CASK protein expression in 
skeletal muscle was performed by western analysis on subcellular cytosolic fractions and 
membrane-enriched fractions (microsomes). These results revealed that CASK protein 
expression in total skeletal muscle homogenates was nearly absent, while CASK still remained 
expressed in lower levels in microsome membrane-enriched fractions. Due to the small amount 
of CASK still present in the membrane fraction via western analysis, we next conducted 
immunohistochemical analysis to verify these findings and determine the localization of the 
remaining CASK. Immunofluorescence was conducted on cross-sections of WT/+ and CASK 
SkM cKO quadriceps with a polyclonal CASK antibody. Confocal microscopy revealed that 
CASK expression had remained unaltered at the primary gutter of the NMJ in CASK cKO mice 
when compared to WT/+ littermate controls (figure 2-4). These results indicate that the HSA 
promoter coupled to Cre recombinase does not result in complete knockout of CASK expression 
in all skeletal muscle subcellular areas. Although CASK was not ablated completely from the 
NMJ, CASK protein levels in membrane-enriched fractions appeared reduced as compared to 
controls. This model, therefore, represents a cKO model in which CASK is lost from the cytosol 
and significantly reduced in the sarcolemma, but is still present at the NMJ. 
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No Observable Degenerative Phenotype is Associated with a Loss of Non-Synaptic CASK 
 In order to assess the physiological effects of a loss of CASK from the cytoplasm of 
skeletal muscle fibers, we began to phenotypically characterize the HSA-CASK cKO mice to 
delineate any essential functions of non-synaptic CASK. Using this model, any characterized 
degeneration, loss of function, or altered levels and localizations of CASK protein interactors can 
be attributed to a loss of non-synaptic CASK. To begin the characterization of the CASK SkM 
cKO mice, morphological analysis was conducted via H&E staining on sections of WT/+ and 
CASK cKO quadriceps (figure 2-5). These results demonstrated that levels of inflammation and 
degeneration appeared relatively low in both CASK SkM cKO and WT/+ sections. There were 
also no observable differences in fiber size between the two genotypes. Newly regenerated 
muscle fibers have recently undergone degeneration and can serve as an indicator of recent 
skeletal muscle degeneration. Therefore, degeneration was quantified by counting the number of 
centrally nucleated fibers, a characteristic of a muscle fiber that has undergone degeneration and 
has been newly regenerated. There were no statistically significant differences in the number of 
centrally nucleated fibers between genotypes (data not shown). 
 Despite the observation that CASK ablation does not occur at the synapse, we chose to 
analyze the topology of the NMJ across genotypes. We postulate that cytosolic CASK may be 
involved in the trafficking of specific channels and receptors to the NMJ, and that there would be 
a loss of potential protein trafficking to the NMJ in the CASK SkM cKO mice when compared to 
WT mice, thus affecting its morphology. The topology of the NMJ was viewed for both WT/+ 
and CASK cKO mice. Fluorescent-conjugated α-bungarotoxin staining can be used to stain the 
primary gutter of the postsynaptic NMJ so that the morphology of the NMJ can be viewed, 
forming a “pretzel-like” architecture (figure 2-6). NMJ circumference was traced so that the 
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surface area could be measured and compared quantitatively across genotypes. Results showed 
no statistically significant difference between the sizes of the WT/+ and CASK cKO NMJs. 
There was also no observable difference in the amount of branching or continuity in NMJ 
topology across genotypes. Confocal analysis also revealed that candidate receptor and channel 
CASK interactors appeared normal at the NMJ. 
 To test for any weaknesses in force generation from CASKSkM cKO skeletal muscle, 
physiological experiments were conducted on dissected EDL muscles from WT/+ and CASK 
SkM cKO mice. By stretching the muscle and determining the length at which maximum 
isometric force is achieved, we can determine differences in muscle strength between genotypes. 
Results showed no discernible differences between WT and cKO mice, suggesting that muscle 
strength is not affected by a loss of cytosolic CASK in skeletal muscle (data not shown).  
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Loss of CASK Alters Dlg Protein Expression Levels and Subcellular Localization in CASK SkM 
cKO Mice 
 In addition to protein channels and receptors, CASK has also been shown to interact and 
bind with other MAGUK proteins in vivo. To determine if any MAGUK proteins were being 
upregulated in response to cytosolic CASK loss, we performed western analysis on CASK SkM 
cKO and WT subcellular fractions (figure 2-7). Because Dlg is already known to interact with 
CASK in skeletal muscle, we decided that Dlg would be the best protein candidate to analyze 
first. Western analysis demonstrates that Dlg protein levels in nuclear, total homogenate, 
cytosolic, and membrane fractions were all increased in CASK SkM cKO mice compared to 
their WT/+ littermates. Dlg upregulation may occur in response to a loss of cytosolic CASK due 
to the similar function they share in skeletal muscle. 
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As a means of confirming the Dlg Western analysis and analyzing the subcellular 
localization of the excess Dlg in CASK SkM cKO mice, we performed immunohistochemical 
analysis on fixed 8 µm quadriceps cross-sections from WT/+ and CASK SkM cKO mice. 
Confocal microscopy revealed that excess Dlg was found localized to the cytoplasm and at 
membranes in cKO mice when compared to WT/+ mice, while similar localization patterns were 
seen at the NMJ in both genotypes (figure 2-9). This further supports the role that Dlg 
upregulation occurs to compensate for the loss in function that arises from ablation of 
cytoplasmic CASK.  
Since Dlg was being upregulated, we also wanted to know if any other MAGUK protein 
levels were being altered in response to a loss of non-synaptic CASK. To determine this, we 
performed western analysis on WT/+ and HSA-Cre CASK SkM cKO subcellular fractions using 
a Pan-MAGUK antibody that recognizes a conserved MAGUK consensus domain (figure 2-8). 
This analysis illustrated that MAGUKs other than Dlg may also be altered in skeletal muscle in 
response to a loss of cytoplasmic CASK. 
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We next examined the localization of Glutamate Receptor Interacting Protein (GRIP), 
another PDZ containing protein and known CASK interactor in skeletal muscle (figure 2-10) 
(Sanford, personal communication). GRIP is responsible for binding glutamate receptor subunits, 
and is composed of 7 PDZ domains. Immunohistochemical analysis, however, revealed that 
there were no major differences in GRIP localization between WT/+ and CASK SkM cKO mice. 
This shows that a loss of non-synaptic CASK does not alter levels of the CASK protein 
interactor GRIP. 
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Discussion 
 In this study, we hoped to test the hypothesis that a complete ablation of CASK from 
skeletal muscle would result in an observable phenotype. However, with the HSA-Cre model, 
CASK was not completely knocked out of skeletal muscle. In fact, CASK protein expression had 
been knocked out in the cytoplasm, but remained expressed at the NMJ. This model, however, 
did provide us with a means to differentiate a function between cytoplasmic CASK and CASK 
present at the NMJ. 
In the current HSA-Cre model, we found that cytoplasmic CASK is involved in the levels 
and localization of other protein interactors, and a knockout of CASK in the cytoplasm results in 
alterations in these levels. However, no other discernible phenotype could be noted. There were 
no signs of abnormal skeletal muscle maintenance and development, nor were there any signs of 
histological abnormalities or muscle degeneration.  
A likely explanation for the lack of phenotype in the CASK SkM cKO model is the 
probability that CASK and Dlg share similar functions in skeletal muscle (Nix et. al. 2000). As 
seen in KO models of CASK and Dlg, when function of either protein is lost, both models 
exhibit similar debilitating phenotypes, followed by death within 24 hours (Laverty et. al. 1998, 
Caruana et. al. 2001). This suggests that CASK and Dlg may be implicated in the same 
developmental pathway in skeletal muscle. The upregulation of Dlg seen in the CASK SkM cKO 
mice may compensate for the loss of cytosolic CASK function, thus preventing the 
characterization of an observable phenotype. The altered expression levels of MAGUK proteins 
between CASK SkM cKO and WT/+ protein homogenates seen through Western analysis may 
also suggest the possibility of other MAGUK proteins that share redundant functions with 
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CASK. These results demonstrate the importance of the interaction of CASK and Dlg, as well as 
the function of MAGUK proteins in skeletal muscle development. 
The lack of CASK ablation at the NMJ in the HSA-Cre CASK cKO may be due to our 
choice of promoter. The HSA promoter was chosen for its availability and selectivity for skeletal 
muscle. Miniou et al had previously created the HSA-Cre line of mice, and they were available 
for purchase through Jackson Laboratories. Since then, a number of other studies had made use 
of the Cre/lox system under the direction of the HSA promoter, yielding skeletal muscle specific 
knockout models. The HSA-Cre system was designed to be expressed in skeletal muscle starting 
at approximately e9; however expression of the system in synaptic nuclei, the nuclei in skeletal 
muscle located directly beneath the neuromuscular junction, has not been verified. Synaptic 
nuclei specifically express other genes whose products are specifically localized to the post-
synaptic membrane, such as acetylcholine receptors and utrophin (Grady et. al. 2005, Jevsek et. 
al. 2006, Kummer et. al. 2006, Schaeffer et. al. 2001). It is possible that CASK is effectively 
knocked out throughout cytoplasm, but still getting transcribed in synaptic nuclei and being 
specifically trafficked into the NMJ. To account for this, we could create a model in which Cre 
recombinase expression was driven under the direction of a different promoter that was known to 
be expressed within synaptic nuclei. However, no such Cre transgenic line has yet been made 
available. 
Future experiments with the HSA-Cre CASK SkM cKO mice may include the isolation 
of myofibers in cell culture, which will provide us with the opportunity to further examine the 
effects on CASK protein interactors with the ablation of non-synaptic CASK. Microarray 
analysis can also be performed across the different genotypes, allowing us to determine which 
genes may be more or less transcribed in response to a loss of non-synaptic CASK. 2-
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dimensional gel proteomic analysis would be able to provide us with more complete data about 
post-transcriptional modification or altered expression levels of CASK protein interactors. To 
verify that CASK is still getting transcribed in synaptic nuclei in the HSA-Cre CASK SkM cKO 
model, in situ hybridization can be performed to determine the presence of the lox P flanked 
exon 1 of the CASK gene in synaptic nuclei. A collaborator is currently developing an 
acetylcholinesterase promoter-driven Cre in an adeno-associated viral (AAV) vector that we 
eventually hope to test in 4-week old HSA-Cre CASK SkM cKO mice. This will knock out the 
remaining synaptic CASK after development to determine CASK function at the NMJ in adult 
skeletal muscle after development. However, to better understand the functions of CASK in 
developing skeletal muscle, a more complete CASK cKO model must be constructed in which 
Cre recombinase is under the direction of a skeletal muscle-specific promoter that is expressed 
earlier in development so that CASK deletion is present in synaptic nuclei.  
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III  
Characterization of Total CASK Function in Skeletal Muscle 
Introduction 
 CASK has been shown to be involved in protein trafficking and receptor clustering in 
neuronal cultures (Atasoy et. al. 2007, Butz et. al. 1998, Daniels et. al. 1998, Hong et. al. 2006, 
Hsueh et. al. 1998, Hsueh et. al. 2006, Jeyifous et. al. 2009, Kim et. al. 1995, Kornou et. al. 1997, 
Leonoudakis et. al. 2004, Maximov et. al. 1999, Samuels et. al. 2007). The presence of CASK in 
skeletal muscle has led to the hypothesis that CASK may play a similar role here in trafficking 
proteins to the NMJ. We explored this hypothesis in our previous aim by looking for the 
presence of a degenerative phenotype associated with a loss of non-synaptic CASK. However, 
the localization of CASK to the NMJ suggests that CASK may also play a significant role at the 
junction of the skeletal muscle with the motor neuron. To determine the role that CASK plays at 
the NMJ, a complete cKO model must be generated in which CASK is not only lost from the 
cytoplasm and reduced in the peripheral membrane, but completely absent in skeletal muscle 
tissue. Using this model, it will be possible to gain a broader insight into the specific mechanisms 
by which CASK functions in vivo in skeletal muscle.  
 To further delineate the mechanisms by which CASK functions at the NMJ, our lab 
generated cKO models of CASK ablation in the cytoplasm, membrane, and NMJ of murine 
skeletal muscle. Once again, the Cre/lox recombination system was used to interrupt the CASK 
gene by selectively excising exon 1 (Atasoy et. al.2007). The Cre transgene in this model is 
expressed under the direction of the myogenic factor 5 (Myf5) promoter. Myf5 is a myogenic 
regulatory factory, involved in the differentiation and development of mature skeletal muscle 
(Buckingham et. al. 2003, Brand-Saberi 2005, Perry and Rudnick 2000, Rescan 2001, Shih et. al. 
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2008). It becomes expressed early in development before NMJ formation and the specialization 
of synaptic nuclei. To achieve skeletal muscle specific ablation, mice expressing the Myf5-Cre 
transgene were bred to mice that contain the floxed CASK allele generated by Atasoy et al. 
(Atasoy et. al. 2007). Generation of a more complete CASK SkM cKO model will allow for a 
more comprehensive analysis of the role of CASK function in skeletal muscle and at the NMJ. 
As we have previously demonstrated, a loss of non-synaptic CASK protein expression 
does not result in any gross, morphological, or functional phenotypes. However, it has been 
shown that a complete ablation of CASK results in neonatal lethality in mice (Laverty et. al. 
1998). Given this data, we postulate that CASK may play a more crucial role in muscle 
development and at the mature NMJ, and that a loss of synaptic CASK will result in a 
pathological phenotype. We hypothesize that CASK may be involved in synaptic scaffolding and 
its role in muscle is essential for normal function and development. 
  
Methods 
The Myf5-Cre Transgenic Line and CASK Knockout Models 
 The Cre/lox method of gene excision was once again used for the generation of the new 
CASK SkM cKO model. CASK floxed mice, generated by the Sudhof laboratory and used in the 
creation of the HSA-Cre CASK SkM cKO model, were purchased from Jackson laboratories. 
Mice that contain a Cre expression cassette knocked into the muscle-specific Myogenic factior-5 
(Myf5) promoter were used to generate tissue-specific CASK ablation at an earlier point in 
muscle development. Myf5 is a myogenic regulatory factor expressed in developing skeletal 
muscle. In order to generate the new CASK SkM cKO mice, female CASK floxed heterozygous 
mice were mated to male Myf5-Cre mice to create male progeny that contain both the floxed 
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CASK allele and the Myf5-Cre allele. Because CASK is X-linked, these mice are predicted to 
have a complete ablation of CASK in skeletal muscle tissue starting by day e8 in development 
when Myf5 is normally expressed in developing myotubes (cKO). The progeny from this cross 
also includes wild type littermates that either contain or lack the Myf5-Cre transgene (WT/+ and 
WT/-, respectively). Flox/- males and Het/- females are also present in this generation. 
 All mice are housed in a fully-equipped vivarium at The Ohio State University under an 
IACUC approved protocol to Dr. Jill Rafael-Fortney. Mice are kept on a standard 12 hr day/night 
cycle and were provided food (7012 Teklad LM-485 Mouse/Rat Sterilizable Diet, Harlan 
Laboratories) and water ad libitum. 
 
Genotyping 
 Genomic DNA was obtained from the tail of 3 week-old mice at weaning or from the tail, 
head, or placenta of mice removed prenatally from pregnant females and analyzed via PCR. To 
test for the presence of the Myf5-Cre transgene, the previously described HSA-Cre F/R primers 
by Miniou et al were used to generate a 790 bp product from within the Cre region. Genotyping 
for presence of the floxed allele was performed using the two sets of primers previously 
described in Chapter 2. The first primer set, CASK Neo Rejuv F/R, was designed to screen for a 
region within the Neo cassette, yielding a 610 bp product. The second primer set was used in 
conjunction with CASK Neo Rejuv F/R to confirm the presence of the floxed allele, and are as 
follows: IMR 6389, located within the Neo cassette and IMR 6390, located within the CASK 
genomic sequence, yielding a 256 bp product. To test for the presence of the wild type allele, the 
primer pair SSC 221 and IMR 6388 was designed to screen for a DNA sequence around the Neo 
cassette of the targeting sequence generated by the Sudhof lab (primers designed by Jackson 
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Labs). As previously described, these primers yielded a 490 bp product for the WT allele and a 
1,400 bp product for the floxed allele. All PCR reaction products were run on 1% agarose gels 
(0.02% ethidium bromide) and photographed under ultraviolet light. 
 
Histological Analysis 
 Unfixed total hindlimbs were dissected from entire litters of prenatal mice (e12-20) and 
embedded in OCT (optimal cutting temperature) cryoprotective mounting medium (Tissue-Tek, 
Hatfield, PA). Because of the small size of the mice, the entire leg was used to maintain the 
integrity of the skeletal muscle tissue. Tissues were then slow-frozen on liquid nitrogen-cooled 
isopentane and stored at -80
o
C.  Frozen tissue was cut into 8 µm cross-sections on a cryostat. To 
view the histology of the skeletal muscle tissue, slides were fixed in 100% ethanol and stained 
with hematoxylin and eosin (H&E) using a standardized protocol.  
 
Immunohistochemistry 
 Immunohistochemical analysis was conducted on 8 µm cross-sections of unfixed frozen 
legs from WT/-, WT/+, Flox, and CASK cKO prenatal mice (e12-20). Sections were first 
blocked in 1% gelatin in potassium-phosphate buffered saline (KPBS) for 15 min before being 
washed in KPBS for 15 min. Following the washes, sections were incubated for 2 hours in a 
primary antibody solution consisting of anti-dystrophin/utrophin (1:10,000) diluted in KPBSG 
(KPBS + 0.5% gelatin) plus normal goat serum (1%). Sections were then washed 3 x 5 min in 
KPBSG. Following rinsing, sections were incubated in a secondary antibody solution that 
consists of CY3 anti-rabbit secondary antibody (Jackson Laboratories, 1:200), Alexa 488-
conjugated α-bungarotoxin (Molecular Probes, Inc., 1:1000), and normal goat serum (1%) in 
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KPBSG for 1 hour. α-bungarotoxin was used to fluorescently label the acetylcholine receptors at 
the NMJ. After incubation, sections were once again washed in KPBSG 3 x 5 min. Slides were 
then mounted in Vectashield ® (Vector Labs, Burlingame, CA) and DAPI (500 ng/mL ) before 
being coverslipped. Images were captured with a Nikon Eclipse E800 microscope and a SPOT-
RT slider digital camera and SPOT® software.  
 
Results 
Generation of Myf5-Cre CASK SkM cKO Mice 
 The Myf5-Cre CASK SkM cKO mice were again generated via the Cre/lox 
recombination system. Mice that possess the floxed CASK allele were mated to mice that 
express the Cre transgene from the Myf5 promoter to interrupt the CASK gene specifically in 
skeletal muscle tissue, creating a generation of mice that include: CASK SkM cKO males, flox/- 
males, het/+ females, het/- females, and WT/+ and WT/- mice (refer back to figure 2-2). 
 
Myf5-Cre CASK SkM cKO Mice are Not Born at Mendelian Ratios 
 Under the aforementioned breeding scheme, few mice were determined to be CASK SkM 
cKO mice at weaning when compared to littermates. Observed Mendelian ratios were not as 
expected, and there were very few viable CASK SkM cKO mice (figure 3-1). As this trend was 
observed, daily observations of matings were initiated in an attempt to catch any dying pups. 
Four dead pups were genotyped as cKOs but sections could not be collected due to the 
deterioration of the samples. No dead pups were observed after 48 hours after birth. To account 
for the possibility that CASK SkM cKO mice may be dying prior to or at birth, Caesarean 
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sections were performed on Het/- female mice after mating with Myf5-Cre males to obtain DNA 
for genotyping and quadriceps cross-sections for histological analysis. 
 Caesarean sections were performed on mice approximately 16.5 days following 
fertilization. Timed matings were set up to determine the exact day that fertilization took place. 
At e16.5, prenatal mice were dissected to obtain tissue for DNA extraction and staining. Because 
of the small size of the prenatal mice, individual quadriceps muscle could not be isolated without 
sacrificing the integrity of the tissue. To obtain sections for staining, both legs were removed and 
placed in OCT to be frozen and cut.  
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Myf5-Cre CASK SkM cKO Mice May Exhibit a Degenerative Phenotype 
 Myf5-Cre CASK SkM cKO mice were removed from the pregnant female at e16.5 and 
dissected for tissue. Upon dissection,  Myf-5-CASK cKO mice appeared smaller and 
underdeveloped when compared to the rest of the litter. Histological analysis on these mice 
reveals an apparent muscle pathology when compared to WT/+ littermate controls. The muscles 
in the hindlimb of the cKO mice were less developed than those of the littermates at the same 
age and were smaller in circumference than wild-type mice. Muscle fibers were less defined and 
fiber membranes appeared relatively uneven in the Myf5-CASK cKO mice. This suggests that a 
complete loss of CASK during development results in abnormal skeletal muscle myogenesis. 
 To determine the extent to which development has slowed, cKO hindlimbs were 
immunostained with an antibody that binds dystrophin and utrophin, two skeletal muscle fiber 
markers that are localized around developing and mature skeletal muscle fiber membranes and 
used to detect differentiated muscle fibers. Dystrophin staining revealed that the Myf5-CASK 
cKO mice appear to have much less differentiated muscle that WT/+ littermates. Co-staining 
with the fluorescent nuclear dye DAPI also reveals a high degree of disorganization among the 
skeletal muscle fibers in the Myf5-CASK cKO hindlimb as compared to littermate controls. This 
data suggests that synaptic CASK plays an essential role in myogenesis. 
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Discussion 
 In this study, we hoped to develop a more complete CASK SkM cKO model in which 
CASK was completely ablated throughout skeletal muscle tissue. Unlike the previous model in 
which only non-synaptic CASK was lost, Cre is under the direction of the Myf5 promoter, which 
should is expressed earlier in development at e8. Myf5 is the first of the myogenic regulatory 
factors to be expressed and it is expressed in the epaxial lip of the dermomyotome (Tajbakhsh et. 
al. 1996). This allows for the complete interruption of the CASK gene in all nuclei so that there 
won’t be any protein expression or subcellular localization of CASK within skeletal muscle 
tissue. 
 Our first observation with the Myf5-Cre CASK SkM cKO mice was the low number of 
mice that exhibited both the floxed CASK allele and expression of the Cre transgene. Compared 
to expected numbers of mice as predicted by Mendelian genetics, there were few observed 
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CASK SkM cKO mice born. This piece of evidence led us to the hypothesis that Myf5-Cre 
CASK SkM cKO mice may be dying in utero or very soon after birth. To account for this 
observation, we began performing Caesarian sections on female Het/- mice with litters on e16.5. 
Initial gross observation of the dissected prenatal mice revealed a potential phenotype, as cKOs 
were smaller than their WT littermates. Morphological analysis confirmed that the skeletal 
muscle fibers of the Myf5-Cre CASK SkM cKO mice were less organized and developed around 
the bones of the lower hindlimb. These findings were confirmed when immunostaining with an 
anti-dystrophin antibody revealed that there were fewer organized, differentiated muscle fibers in 
the Myf5-Cre CASK SkM cKO mice when compared to WT littermate controls. These results 
suggest that synaptic CASK is essential for normal muscle development. 
 Further phenotypic analysis of this mouse model will be necessary to determine the role 
that CASK has on muscle development. As done with the HSA-Cre CASK SkM cKO mouse 
model, future work involves western analysis to confirm that CASK has indeed been completely 
knocked out from skeletal muscle tissue and immunohistochemical analysis with a CASK 
antibody to confirm. Functional analysis can be conducted as well to determine any muscle 
weakness that results from a loss of CASK in skeletal muscle. In addition, immunohistochemical 
and western analysis can be performed to determine the effects a complete loss of synaptic 
CASK has on the levels and localizations of other CASK protein interactors. NMJ localization 
can be viewed by co-staining with α-bungarotoxin to determine any differences in the 
localization of other specific proteins recruited to the NMJ early in development between cKO 
mice and their littermate controls of the same age. Proteomic analysis can also be conducted on 
skeletal muscle homogenates from these mice to determine which proteins are being affected by 
a loss of CASK and how.  
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 Additionally, future experiments can be conducted to further the explanation of why a 
degenerative phenotype is occurring. Transmission electron microscopy can be conducted 
between cKO and WT mice to examine if sarcomerogenesis is affected. Also, we can determine 
if the phenotype is cause by altered proliferation through Ki67 staining, apoptosis through 
ApoTaq detecton, or fiber number or MHC expression. Furthermore, if the Myf5-CASK cKO 
mice show that CASK is involved in myogenesis, we can examine embryonic myogenesis in a 
murine model that overexpresses the CASK full-length protein (Sanford et. al. 2004) to 
determine if this increases the rate of myogenesis. The research being conducted on this aim is in 
its early stages and there is still much to be done. However, the finding that there may be a 
potential degenerative phenotype associated with a complete ablation of CASK in skeletal 
muscle will drive further study of the CASK protein. 
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IV 
The Role of CASK as a Protein Kinase and Its Phosphorylation 
Introduction 
 CASK contains two protein domains that share similar sequence homology to functional 
kinases and have led to the hypothesis that CASK may play a role in protein phosphorylation: the 
guanylate kinase (GK) domain and the Ca
2+
/calmodulin kinase-like (CaMK) domain. The GK 
domain is found at the C-terminus end of CASK and is named for its sequence similarity to the 
yeast guanylate kinases. However, the GK domain found in MAGUKs lacks the amino acid 
residues for binding ATP, and thus is predicted to not possess any actual phosphorylative ability 
(Kuhlendahl et. al. 1998, McGee and Bredt 1999, Olsen and Bredt 2003). Instead, the primary 
functions of the GK domain are to confer scaffolding properties to CASK via its interactions 
with the SH3 domain of other MAGUK proteins, as well as participate in intramolecular 
interactions with its own SH3 domain (MacLennan and Edwards 1990, McGee and Bredt 1999, 
McGee et. al. 2001, Nix et. al. 2000, Shin et. al. 2000, Tavares et. al. 2001). The CaMK domain 
is completely unique to CASK and was named for its similar sequence homology to the CaMK 
family of proteins, notably, CaMKII (Hata et. al. 1996). CaMKII is a serine/threonine specific 
protein kinase known to be regulated by the Ca
2+
/calmodulin complex. CaMKII has been shown 
to phosphorylate both AMPA and NMDA receptor subunits in central nervous system synapses, 
including the subunits GluR1 and NR2B. The phosphorylation of these glutamate receptor 
subunits has been postulated to play a major role in synaptic plasticity and long term 
potentiation. The association of CaMKII with MAGUK proteins has been shown to both enhance 
its catalytic activities and to phosphorylate MAGUKs such as PSD-95 and Dlg (Song et. al. 
2004, Yan et. al. 2004, Yoshimura et. al. 2000 and 2002). 
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Despite the similar sequence homology of the CaMK domain to CaMKII, it had not been 
believed to function similarly. Due to its lack of Mg
2+
-binding sites, the CaMK domain had been 
classified as a catalytically inactive pseudokinase and has been previously thought to be 
ineffective (Boudeau et. al 2006). However, recent evidence has shown that the CaMK domain 
adopts a catalytically active conformation that binds ATP without Mg
2+
 and catalyzes 
phosphotransfer to neurexin-1, itself, and possibly other CASK protein interactors. Neurexin-1 is 
a synaptic cell-adhesion protein that binds CASK by means of its PDZ domain (Ichtchenko et. 
al. 1996, Ushkaryov et. al. 1992). The CASK-neurexin complex has been shown to be a 
substrate for phosphorylation by the CaMK domain in neuronal cultures. CASK is unique in that 
it is the first known protein of its kind to be catalytically active in the absence of Mg
2+ 
(Mukherjee et. al. 2008). This allows CASK to function faster in the Mg
2+
-poor environment of 
developing skeletal muscle where other kinases catalyze more slowly, making CASK a very 
important protein to investigate as an active kinase in developing skeletal muscle. 
 Interestingly, there is much evidence that shows that the CASK interactor Dlg is 
phosphorylated and that this phosphorylation regulates its activities at synapses (Massimi et. al. 
2006, Gardner et. al. 2006, Zhang et. al. 2007). At the Drosophila NMJ, Dlg has been shown to 
be phosphorylated by the PAR-1 kinase at a conserved serine residue in the GK domain. This 
phosphorylation was shown to regulate the trafficking of Dlg between extrasynaptic and synaptic 
compartments. Furthermore, phosphorylation of Dlg by PAR-1 plays a major role in the 
development of and synaptic transmission at the Drosophila NMJ (Zhang et. al. 2007). Recent 
evidence has shown that CaMKII phosphorylates both the L27 and PDZ domains of Dlg as well. 
This phosphorylation ultimately aids in the regulation of GluR1 receptor subunits at synapses 
(Nikandrova et. al. 2010). 
50 
 
  While CASK may possess the ability to function as an active protein kinase, it also may 
play an important role as a protein substrate for phosphorylation. CASK has been shown to be 
phosphorylated by multiple proteins, including protein kinase A (PKA) and cyclin-dependent 
kinase 5 (Cdk5) (Huang et. al. 2010, Samuels et. al. 2007). Phosphorylation of CASK by PKA 
causes an upregulation of the interaction between CASK and the TBR-1 transcription factor. 
This enhanced interaction ultimately results in increased expression of the NMDA receptor 
subunit, NR2B (Huang et. al. 2010). Perhaps the most striking evidence for the need for 
investigation of phosphorylation of CASK has come from studies of the phosphorylation of 
CASK by Cdk5. CASK has been shown to be phoshphorylated by Cdk5, the only member of a 
family of proteins that is not involved in the regulation of the cell cycle. When Cdk5 is absent in 
vivo, CASK is no longer phosphorylated in a central nervous system model. Furthermore, when 
Cdk5 is interrupted, aberrant neuronal synapse formation is present. Cdk5 deficient mice show a 
significant reduction in CASK expression at cell membranes, which has been directly attributed 
to a lack of phosphorylation of CASK, as shown by mutational analysis of its serine residues 
(Samuels et. al. 2007).  Mice that are deficient in Cdk5 also demonstrate aberrant motor axon 
projection and acetylcholine receptor clustering (Fu et. al. 2005). Taken together, these results 
suggest that investigating the phosphorylation of CASK in skeletal muscle will likely provide 
valuable insight into the role of CASK in synaptic function and the tissue as a whole. 
While the CaMK domain is capable of kinase activity in neuronal cultures, there is no 
data as to the degree to which the CaMK domain acts as a functional protein kinase in skeletal 
muscle. Our HSA-Cre CASK SkM cKO model represents a loss of non-synaptic CASK in 
skeletal muscle, so we turned to this model to determine the extent to which CASK 
phosphorylation and kinase activity regulate normal muscle development and function. In 
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addition, we looked to two other murine models in which CASK expression was altered. One 
model overexpresses the full-length CASK protein (CASK FL+) and the other overexpresses a 
truncated version of the CASK protein (CASK Δ+) (Sanford et. al. 2008). These models allow us 
to examine the extent to which CASK phosphorylation and kinase activity regulate normal 
muscle development and function in skeletal muscle. Dlg has been shown to be both a substrate 
for phosphorylation in vivo and a known CASK protein interactor, so we investigated the 
interaction between CASK and Dlg in vitro as well (Massimi et. al. 2006, Gardner et. al. 2006, 
Zhang et. al. 2007). We hypothesize that CASK functions as an active protein kinase in skeletal 
muscle and is involved in the phosphorylation of Dlg and other CASK protein interactors. In 
addition, we hypothesize that phosphorylated CASK may also play an essential role in the 
formation of the neuromuscular junction. 
 
Methods 
Immunoprecipitations 
 Immunoprecipitations were performed using total skeletal muscle homogenates from 12-
wk old HSA-Cre CASK SkM cKO mice and their littermate controls in Newcastle Buffer. 
Skeletal muscle homogenates (30 µL) were preadsorbed with protein G sepharose (Amersham 
Biosciences) for 1 hour. The supernatant was then incubated with 13 µL of monoclonal CASK 
antibody (Chemicon) for ≥3 hours. The mixture was next incubated with protein G sepharose 
overnight. The protein-bead suspension was then spun down and the supernatant was kept as the 
unbound fraction. Beads were washed three times and boiled in 30 µL of Laemmli dye to release 
bound material, which was then run on an 8% SDS-PAGE gel and immunoblotted with anti-
Cdk5. 
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Protein Isolation and Purification 
 E. coli BL21 cells were transformed with a pGEX plasmid vector containing either the 
Dlg or the CASK cDNA sequence linked to the glutathione-S-transferase (GST) fusion protein 
gene using a standardized heat-pulse method (Stratagene). Cells were then grown at 37
o
C in 
2XYT media + ampicillin (75µg/mL) to a dilution of 1:100. The cells were allowed to grow an 
additional 3 hours before induction of GST-CASK or GST-Dlg transcription with isopropyl β-D-
1-thiogalactopyranoside (IPTG, 1 mM) for 4-5 hours. Cells were then spun down for 10 min at 
5,000 x g and resuspended in 1/20 their original volume in phosphate-buffered saline (PBS). 
Cells were lysed and spun down at 10,000 x g for 5 min at 4
o
C to separate soluble proteins from 
cellular debris. The supernatant was mixed with prepared glutathione beads (1/1,000 original 
volume of cells) and incubated overnight at 4
o
C. Following incubation, cells were spun down at 
1,000 x g for 5 min to sediment the matrix. The bead pellet was washed three times in cold PBS. 
The fusion protein was then eluted by adding 1 mL of 50 mM Tris-Cl, pH 8.0, 5 mM reduced 
glutathione solution. The eluate fraction was then isolated and stored at -80
o
C. Fractions from the 
pre-induction, post-induction, cellular debris, soluble protein, wash, and eluate stages were run 
out on 8% SDS-PAGE gels and subsequently stained with Coomassie blue to confirm the 
presence of the purified fusion protein in the eluate. 
 
Western Analysis 
Total skeletal muscle was collected from 12-week old WT, Flox, and CASK SkM cKO 
mice and homogenized in Newcastle buffer (75 mM Tris, pH 6.8, 3.8% sodium dodecyl sulfate 
(SDS), 4 M urea, 20% glycerol). Protein concentrations were determined using the DC protein 
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assay (Biorad) followed by subsequent absorbance measurements at 750 nm wavelength. 50 µg 
of protein per sample was then run out on 8% SDS-polyacrylamide gel electrophoresis (SDS-
PAGE) gels at 80 V for approximately 3 hours. After separation, proteins were electrically 
transferred from SDS-PAGE gels to nitrocellulose (Whatman International) or polyvinylidene 
fluoride (PVDF, Bio-Rad) at 80 V for 90 min using a wet transfer apparatus (Bio-Rad). 
Nitrocellulose western blots were then blocked in 3% bovine serum albumin (BSA) in Tris-
buffered saline plus 0.1% Tween-20 (TBST) and 1% normal goat serum for 1 hour.  Following 
blocking, blots were then incubated in a primary antibody solution consisting of a primary 
antibody and 1% normal goat serum in TBST for 2 hours. Primary antibodies include CASK 
polyclonal (Zymed, 1:250), Dlg monoclonal (Transduction Laboratories, 1:250), polyclonal 
phosphoserine (Invitrogen, 1:250), polyclonal phosphotyrosine (Cell Signaling, 1:250), and 
polyclonal phosphothreonine (Millipore, 1:250). Blots were then washed 3 x 15 min in TBST 
and incubated with horseradish peroxidase (HRP)-conjugated goat anti-rabbit secondary 
antibody (Jackson Laboratories, 1:10,000) in TBST with 1% normal goat serum for 1 hour. 
Chemiluminescence (Amersham) was used for detection of bound primary antibody on 
nitrocellulose. 
 PVDF blots were used for dual labeling with primary antibodies, and were first blocked 
in 3% bovine serum albumin (BSA) in Tris-buffered saline plus 0.1% Tween-20 (TBST) and 1% 
normal goat serum for 30 min. Blots were then incubated overnight in a primary antibody 
solution consisting of two distinct primary antibodies raised in different species for dual labeling 
and 1% normal goat serum in TBST. Primary antibodies used include Dlg monoclonal (UC 
Davis, 1:250), polyclonal phosphoserine, and GluR2 monoclonal (UC Davis, 1:250). Blots were 
then washed 3 x 15 min in TBST and incubated with a fluorochrome-conjugated goat anti-rabbit 
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secondary antibody (Licor Biosciences, 1:10,000, detectable at a wavelength of 680 nm) and a 
fluorochrome-conjugated goat anti-mouse secondary antibody (Licor Biosciences, 1:10,000, 
detectable at a wavelength of 800 nm) in TBST with 1% normal goat serum for 1 hour. Bound 
primary antibody was detected using the Odyssey
®
 Infrared Imaging System (Licor Biosciences). 
 
Proteomic Analysis 
 300 µg of homogenized total skeletal muscle protein (quadriceps and hindlimbs) from 
each genotype was passively rehydrated onto 11 cm, pH 4-7, isoelectric focusing (IEF) strips 
(BioRad) and then subjected to first dimension isoelectric focusing using a PROTEAN IEF 
machine (BioRad). The isoelectric focusing conditions were as follows: start voltage at 0 V, end 
voltage was 8,000 V, and the IEF was run for 20- 35,000 V-hr. Protein on the strips then was run 
in the second dimension on a 8-16% gradient gel (BioRad) for 65 min at 200 V, then transferred 
and probed with phosphoserine as described previously in the western analysis section. Spot 
differences were then observed between the different genotypes. Proteomic analysis was 
conducted by Jamie Sanford 
 
Results 
F.L. Dlg Cannot be Effectively Isolated via a GST-Fusion Protein Protocol 
 To begin the characterization of the role of the CaMK domain in skeletal muscle, we 
began work to perform kinase assays to determine the capacity of the CaMK domain of CASK to 
phosphorylate Dlg in vitro. To perform kinase assays in vitro, vectors containing GST-CASK or 
GST-Dlg were cloned into E. coli, and protein synthesis was induced in culture via IPTG 
induction of the lac operon. The fusion proteins were eluted through glutathione beads and the 
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protein isolates were run out on an 8% SDS-PAGE gel and stained with Coomassie blue. Results 
consistently revealed successful isolation of the full length CASK fusion protein in the eluate 
fraction. However, the Dlg fusion protein was fragmented during isolation and Coomassie 
staining revealed that the full length protein could not be retrieved. Western analysis on the 
different fractions retrieved during protein isolation with a polyclonal Dlg antibody was also 
unable to detect the isolated full length protein in the eluate fraction (data not shown).  
 
A Loss of Non-Synaptic CASK Affects the Phosphorylation Levels of Other CASK Interactors 
Because generation of full-length fusion proteins was unsuccessful, we next focused on 
more global approaches to determine what proteins CASK phosphorylates in muscle using our 
transgenic and knockout mouse models. In order to determine whether loss of CASK in 
cytoplasm results in global phosphorylation differences, we performed western analysis on a 
wide array of CASK protein interactors on skeletal muscle homogenates and microsomes from 
both the HSA-Cre CASK SkM cKO mice and their WT/+ littermates. We first probed 
nitrocellulose blots with one of either phosphoserine (Invitrogen, 1:250), phosphotyrosine (Cell 
Signaling Technology, 1:250), or phosphothreonine (Millipore, 1:250). Staining with 
phosphoserine and phosphothreonine revealed distinct differences in the levels of 
phosphorylation among various proteins between total skeletal homogenates of WT/+ and HSA-
Cre CASK SkM cKO mice (figure 4-1). Staining with phosphotyrosine displayed a similar 
number of differences in phosphorylation levels (data not shown). These results suggest that the 
phosphorylation levels of other protein interactors are altered due to a loss of cytosolic CASK in 
skeletal muscle. 
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 Next, we performed western analysis on the same samples and transferred protein gels to 
PVDF membranes. PVDF blots were then dual-labeled with phosphoserine and Dlg or labeled 
with the glutamate receptor subunit GluR2. Dual labeling with phosphoserine and Dlg revealed 
that Dlg is indeed phosphorylated in skeletal muscle at one of its serine residues (figure 4-2). 
Staining for GluR2 revealed that the glutamate receptor subunit is heavier in CASK FL+ 
homogenates that in CASK Δ+ homogenates, suggesting that GluR2 may be phosphorylated in 
response to an overexpression of the FL-CASK protein (figure 4-3). 
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Levels of Other Phosphorylated Proteins are Affected in Response to Levels of CASK Expression 
 To determine if the altered levels of protein phosphorylation was due to a loss of non-
synaptic CASK, proteomic analysis via 2-dimensional gels was run for CASK FL+, CASK Δ+, 
and transgenic negative (Tg-) skeletal muscle homogenates (figure 4-4). Proteomic analysis 
separates proteins based on both size and charge so that individual protein spots can be 
visualized. Analysis revealed drastic spot differences between the three genotypes, suggesting 
that CASK expression plays a major impact on the expression and post-translational 
modifications of other proteins in skeletal muscle. 
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CASK May Be Phosphorylated and Interacts with Cdk5 in Skeletal Muscle 
 To begin to determine whether CASK is phosphorylated in skeletal muscle, we 
performed western analysis on WT subcellular fractions of nuclear extract (NE) and cellular 
extract (CE) and probed with CASK polyclonal antibody (figure 4-5). Results showed that the 
CASK band was lower in the NE fraction, implying that the CASK protein is heavier in the 
cytosol than in the nucleus. We hypothesize that the difference in weight of the CASK protein 
between the two fractions implies that CASK is predominantly phosphorylated in the cytosol 
while CASK in the nucleus remains unphosphorylated. 
 
 
 
Because CASK has been shown to be phosphorylated by Cdk5 in neuronal cultures, we 
began to study whether this was the case in skeletal muscle. To determine the degree to which 
CASK becomes phosphorylated in skeletal muscle, we first used western analysis to determine if 
Cdk5 expression was altered in response to changes in the expression levels of CASK (figure 4-
6a). Western analysis was conducted on skeletal muscle homogenates from mice that 
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overexpressed the full length CASK transgene (FL+), mice that overexpressed a truncated 
portion of the CASK transgene (Δ+), wild type mice (Tg-), WT/+ mice, and HSA-Cre CASK 
SkM cKO mice. Results showed that Cdk5 levels remained relatively consistent across 
genotypes, suggesting that upregulating CASK does not result in a concomitant upregulation of 
Cdk5 in skeletal muscle. 
 To determine whether or not Cdk5 interacts with and therefore potentially phosphorylates 
CASK in skeletal muscle, immunoprecipitations were conducted using total skeletal muscle 
homogenates to illustrate the possible binding between CASK and Cdk5 in vivo. 
Immunoprecipitations were conducted with a CASK monoclonal antibody and bound and 
unbound fractions were run out on an SDS-PAGE gel, transferred to nitrocellulose, and probed 
for Cdk5 (figure 4-6b).Results revealed bands that correspond to the Cdk5 protein in the bound 
lane, suggesting that CASK interacts and binds with Cdk5 in skeletal muscle. Further analysis 
will be needed to determine whether this interaction translates to a phosphorylation of CASK by 
Cdk5 in skeletal muscle. 
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Discussion 
 CASK is a unique protein, in that it contains all of the standard binding domains 
characteristic of MAGUK proteins, as well as a specialized CaMK domain capable of protein 
phosphorylation (Hsueh et. al. 2000, Nix et. al. 2000). It has been postulated that this 
arrangement of domains gives CASK an adaptive function in skeletal muscle development. First, 
CASK contains a PDZ domain that may bind to protein substrates and hold them in place for 
phosphotransfer by the CaMK domain (Mukherjee et. al. 2008). The SH3 and GK domains of 
CASK are capable of intramolecular interactions, which may allow CASK to adopt a number of 
different catalytically active conformations to adapt to the different environments of separate 
tissues or throughout development (MacLennan and Edwards 1990, McGee and Bredt 1999, 
McGee et. al. 2001, Nix et. al. 2000, Shin et. al. 2000, Tavares et. al. 2001). In addition, the 
CaMK domain has been shown to be catalytically active without a functional Mg
2+
 binding site, 
a cofactor typically essential for kinase activity. This may allow CASK to be a predominant 
Cdk5 Cdk5 
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kinase in developing skeletal muscle when Mg
2+
 levels are particularly low (Mukherjee et. al. 
2008). 
 Our findings that CASK interacts with Cdk5 in skeletal muscle, coupled with the 
evidence that phosphorylated CASK is implicated in synaptogenesis, may suggest a crucial role 
for CASK phosphorylation in neuromuscular junction formation and/or stabilization. Cdk5 has 
been shown to catalyze phosphotransfer to a number of proteins involved in cell signaling, 
development, and other biochemical pathways, and its involvement with CASK could implicate 
an important role CASK has in cell signaling and NMJ development (Samuels et. al. 2007). 
Further evidence and the study of the interaction between Cdk5 and CASK, however, would be 
necessary to determine a correlation between CASK phosphorylation and NMJ scaffolding and 
formation in vivo. Experiments may include the cotransfection of CASK and Cdk5 in C2C12 
mouse myoblast cells followed by western analysis to see if CASK phosphorylation takes place, 
or in vitro kinase assays between Cdk5 and CASK to confirm the ability for Cdk5 to 
phosphorylate CASK. 
 Our western analysis between nuclear extract and cytosolic extracts with the CASK 
antibody helps to show that CASK itself is indeed phosphorylated in skeletal muscle. However, 
further experimentation is necessary to confirm these data. Additional attempts to perform 
western analysis on homogenates and stain with a functional phospho-CASK specific antibody 
would help to prove that CASK is indeed phosphorylated in skeletal muscle, and that this 
phosphorylation varies depending on the subcellular localization of CASK. Proteomic analysis 
on homogenates with CASK followed by mass spectrometry will also help to determine any 
post-translational modifications or phosphorylation that CASK may be subjected to. 
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 We also looked at the degree to which different levels of CASK expression affects the 
phosphorylation of other proteins in skeletal muscle. Using four models that represent different 
levels of CASK expression (FL+, Δ+, cKO, and Tg-), we were able to observe differences in 
protein levels and modifications in each. Western analysis with a phosphoserine antibody 
revealed differences in protein phosphorylation between WT and cKO mice. A more in-depth 
proteomic analysis revealed significant spot differences between FL+ and Tg- homogenates, and 
to a lesser extent, differences between Δ+ and Tg- homogenates. Further analysis would involve 
cutting individual spots out of the gels and submitting them to the Proteomic Core Facility for 
mass spectrometry. This would allow us to determine the identity of the individual spots so we 
could determine which proteins were being altered due to the overexpression of the full-length 
CASK protein. 
 In addition to mass spectrometry, further analysis of the capacity of the CaMK domain 
and its role in phosphorylation in skeletal muscle would better help us to characterize the role 
that CASK plays in catalytic phosphotransfer in vivo. While we were unable to successfully 
isolate full-length Dlg fusion protein, full-length CASK was successfully isolated, and kinase 
assays could be performed on a number of other known CASK protein interactors in skeletal 
muscle. These interactors include subtypes of the inward-rectifying potassium channel family, 
subunits of the glutamate receptors, other MAGUK proteins, and NMDA receptor subunits. 
Kinase assays on any of these proteins would help to illustrate the role that the CaMK domain 
plays in cell signaling and phosphorylation. 
 While we have made progress in determining the role of CASK phosphorylation and its 
kinase activity in skeletal muscle, there is still much work to be done. In addition to experiments 
involving further proteomic analysis and kinase assays, we can work to determine how a 
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phosphorylation in CASK affects its function. Perhaps CASK phosphorylation plays a role in 
how it functions in receptor trafficking or where it localizes. For example, we can mutate 
phosphorylated residues of CASK to see if it still localizes to the NMJ. While we have only 
skimmed the surface on CASK’s phosphorylative abilities in skeletal muscle, this work lays the 
foundation for determining the differences between the roles of CASK and phosphorylated 
CASK in skeletal muscle. 
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V 
Discussion and Future Directions 
The Adaptive Role of CASK in Skeletal Muscle 
 The studies conducted in this thesis set out to define the role that the neuronal scaffolding 
MAGUK protein CASK plays in mammalian skeletal muscle. To this end, we used the Cre/lox 
recombination system to develop two distinct conditional knockout models in which non-
synaptic CASK was ablated in skeletal muscle (HSA-Cre CASK SkM cKO) or CASK was 
completely knocked out in skeletal muscle (Myf5-Cre CASK SkM cKO) (Hoess et. al. 1985, 
Sternberg et. al. 1981). This differentiation was possible due to the fact that the HSA promoter is 
most likely not expressed in synaptic nuclei, while the Myf5 promoter is transcribed before 
synaptic development and throughout premature skeletal muscle fibers. 
 A characterization of the HSA-Cre CASK SkM cKO mouse model led us to conclude 
that there was no obvious degenerative phenotype present when compared to their WT/+ 
littermate controls. However, we did find alterations in the levels, localizations, and post-
translational modifications of other CASK interactor proteins in skeletal muscle homogenates 
that may be attributed to a loss of non-synaptic CASK. To further determine which proteins are 
in fact phosphorylated or up-/down-regulated, a more in-depth proteomic analysis is required,  
including, but not limited to, 2-dimensional gel analysis in which spot variations between 
genotypes can be cut out and identified via mass spectrometry. 
 While this model did not exhibit a pathological phenotype, the Myf5-Cre CASK SkM 
cKO model, in which CASK is completely knocked out from skeletal muscle, may show a 
degenerative histology. Initial analysis of this model shows that CASK ablation results in 
underdeveloped skeletal muscle fibers in prenatal (e16.5) mice when compared to WT/+ 
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littermate controls. These results have been confirmed by both histological staining with 
hemotoxylin and eosin dyes and immunohistochemical staining with the dystrophin antibody and 
the fluorescent nuclear dye DAPI. Prenatal Myf5-Cre CASK SkM cKO mice may show a gross 
phenotype illustrated by their relatively smaller size when compared to littermate controls of the 
same age. Additionally, there were fewer Myf5-Cre CASK SkM cKO mice observed than 
predicted by Mendelian genetics when compared to all other littermates. Both of these 
observations suggest that the Myf5-Cre CASK SkM cKO mice may be dying in utero. However, 
a much more in-depth phenotypic characterization is required to confirm these results. This may 
require functional analysis to determine the strength of the developed skeletal muscles in the 
prenatal Myf5-Cre CASK SkM cKO mice. 
 A dynamic contrast exists between the phenotypes of the HSA-Cre cKO model and the 
Myf5-Cre cKO model. While a loss of non-synaptic CASK results in no skeletal muscle 
pathology, a loss of synaptic CASK may result in impaired skeletal muscle development and 
prenatal lethality. A major role CASK has been shown to play in neuronal cultures is to funct ion 
in synaptic scaffolding, receptor clustering to the neuronal synapses, and phosphorylation (Hata 
et. al. 1996, Leonoudakis et. al. 2004, Mukherjee et. al. 2008, Sanford et. al. 2004). We 
hypothesize that the role of CASK at the NMJ is most likely similar to the role that CASK plays 
at the synaptic cleft in neurons, and that it functions in the formation and maintenance of the 
NMJ. Further experiments to test this hypothesis would include a comparison of the two models 
to differentiate the cytoplasmic functions of CASK from the synaptic functions of CASK. 
Physiology experiments can be performed to determine if synaptic transmission is altered 
between the two models. We can also do studies with primary tissue culture from the two models 
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to determine where CASK interacts with protein interactors such as glutamate receptor subunits 
and potassium channel subtypes. 
 Further analysis of the Myf5-Cre CASK SkM cKO model is necessary to definitely 
determine why a total loss of CASK is responsible for a degenerative phenotype while a loss of 
non-synaptic CASK is not. Perhaps the amount of CASK that remains expressed at the NMJ in 
the HSA model is sufficient to develop functional skeletal muscle. CASK may play an important 
role in NMJ formation during myogenesis through the trafficking of receptors and channels to 
the NMJ or the phosphorylation of other MAGUKs and synaptic scaffolding proteins in the 
Mg
2+
-poor environment where other kinases are slower to function (Hata et. al. 1996, 
Leonoudakis et. al. 2004, Mukherjee et. al. 2008, Sanford et. al. 2004).  Immunohistochemical 
analysis of the glutamate receptor subunits, the potassium channels, and other known CASK 
protein interactors in cell culture will be necessary to determine whether these essential 
components of the NMJ are being localized normally to the junction without the trafficking 
capabilities of CASK. However, at the present time, we can only infer from the data that synaptic 
CASK alone is sufficient for normal muscle development, and a loss of CASK at the NMJ 
results in abnormal fiber organization and differentiation. 
 
CASK and Protein Phosphorylation 
 Another aim of this study was to determine the phosphorylative capacity of CASK in 
skeletal muscle, and what function phosphorylation of CASK itself plays in skeletal muscle 
function and development. In neuronal cultures, it has been shown that the CaMK domain of 
CASK is capable of phosphorylating the synaptic scaffolding protein neurexin-1, a pre-synaptic 
protein imperative in the scaffolding of the neuronal synapse (Mukherjee et. al. 2008). A focus 
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of this aim was to determine whether CASK played a similar phosphorylative role in skeletal 
muscle and the development of the NMJ. The MAGUK protein Dlg, a known CASK interactor 
in the central nervous system and skeletal muscle was a good initial candidate for 
phosphorylation by CASK in skeletal muscle (Massimi et. al. 2006, Gardner et. al. 2006, Zhang 
et. al. 2007). While full-length Dlg fusion protein was not successfully isolated, studies on the 
role that altered CASK protein expression plays on the phosphorylation of Dlg and other 
candidate protein interactors was studied via western and 2-dimensional proteomic analyses. We 
found that the phosphorylation of a number of proteins is altered in the CASK FL+ and CASK 
Δ+ models as compared to the wild type Tg- models. We also showed that Dlg is indeed 
phosphorylated at one or more serine residues in skeletal muscle. However, further proteomic 
analyses must be completed to determine what other specific proteins are altered and how in 
response to CASK overexpression. 
 In addition to the ability of CASK to serve as a functional kinase, CASK has been shown 
to be phosphorylated by the protein kinase Cdk5 in neuronal cultures (Samuels et. al. 2008). Our 
lab showed through immunoprecipitaion that CASK and the protein kinase Cdk5 interact in 
skeletal muscle, and we hypothesize that Cdk5 plays a similar role in CASK phosphorylation in 
skeletal muscle tissue. This hypothesis is supported by our observation via western analysis that 
CASK is heavier in a cellular extract fraction of total skeletal muscle homogenate than in a 
nuclear extract fraction. This suggests that CASK is phosphorylated in the cytosol, but remains 
unphosphorylated in the nucleus. CASK phosphorylation in the cytoplasm may be significant as 
a means of cell signaling or adopting a conformation conducive to the binding and trafficking of 
protein channels receptors to the NMJ. 
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Limitations 
 There are several limitations within the findings presented in this thesis. First and 
foremost, the HSA promoter did not knock out CASK completely in skeletal muscle, which was 
our initial hope. However, we have generated the Myf5-CASK cKO mice to rectify this. Another 
major setback is the fact that the Myf5-CASK cKO mice die in utero, making it very difficult to 
study the role of CASK at the mature NMJ due to timing issues, as the mature NMJ isn’t fully 
formed until 2 weeks following birth. Experiments can be performed in primary cell culture, but 
this may prove difficult as well since CASK is not recruited to the NMJ by normal agrin 
induction of acetylcholine receptor clustering. However, recent methods have been published in 
which co-culture with motor neurons is possible to study CASK’s function at the NMJ (Das et. 
al. 2010, Guo et. al. 2010). Another limitation was our inability to isolate full-length Dlg fusion 
protein to perform kinase assays. However, future experiments can be conducted in cell culture 
to determine the phosphorylative capacity of the CaMK domain of CASK. In addition, our 
CASK antibodies have been unreliable and reveal a high degree of background staining. 
However, we have yet to try CASK polyclonal antibodies from Santa Cruz Biotechnology, 
LifeSpan biosciences, and Origene, which may solve this dilemma. 
 
Conclusion 
 The data provided in this thesis supports the hypothesis that CASK plays a dynamic role 
in normal skeletal muscle function and development, and that CASK is essential for the normal 
differentiation of skeletal muscle fibers. We have shown that a loss of cytoplasmic CASK results 
in no aberrant muscle pathology, but alters the levels and localizations of other CASK protein 
interactors in skeletal muscle, the consequences of which have yet to be determined. We have 
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also demonstrated that a complete ablation of CASK in skeletal muscle may be responsible for a 
degenerative muscle pathology and abnormal muscle differentiation and development. This data, 
together with the evidence that CASK participates in protein phosphorylation, suggests an 
adaptive role for CASK in developing skeletal muscle and at the NMJ. Further delineation of the 
functions of CASK in developing skeletal muscle may help to elucidate the mechanisms behind 
developing neuromuscular diseases. 
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